Total planned funding: $292,352,622
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Namibia | $292,352,622 |
Organizational Types
| NGO | $80,032,207 |
| Private Contractor | $52,415,587 |
| Host Country Government Agency | $45,281,480 |
| Own Agency | $36,991,881 |
| University | $34,939,169 |
| Unknown | $28,176,431 |
| Parastatal | $5,373,604 |
| Other USG Agency | $4,850,816 |
| Multi-lateral Agency | $2,050,000 |
| Implementing Agency | $1,867,441 |
| FBO | $374,006 |
Program Areas
| Treatment | $86,640,688 |
| Care | $59,373,542 |
| Prevention | $56,679,299 |
| Governance and Systems | $45,688,596 |
| Testing | $22,895,348 |
| Management and Operations | $21,075,149 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $70,689,497 |
| HKID: Care: Orphans and Vulnerable Children | $24,498,552 |
| HVCT: Testing: HIV Testing and Counseling | $22,895,348 |
| HVMS: Management and Operations | $21,075,149 |
| OHSS: Health Systems Strengthening | $20,750,538 |
| HBHC: Care: Adult Care and Support | $19,041,302 |
| HVSI: Strategic Information | $18,805,732 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $17,310,155 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $15,144,062 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $12,192,012 |
| HVTB: Care: TB/HIV | $11,134,496 |
| HTXD: Treatment: ARV Drugs | $10,597,291 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $6,854,174 |
| HLAB: Laboratory Infrastructure | $6,132,326 |
| PDTX: Treatment: Pediatric Treatment | $5,353,900 |
| PDCS: Care: Pediatric Care and Support | $4,699,192 |
| HMBL: Biomedical Prevention: Blood Safety | $3,571,440 |
| HMIN: Biomedical Prevention: Injection Safety | $1,607,456 |
Top Partner Programs
Not Available:
$26,604,773
Countries/Regions
Potentia Namibia:
$25,852,156
Countries/Regions
University of Washington:
$23,707,985
Countries/Regions